ClinicalTrials.gov
ClinicalTrials.gov Menu

Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02060162
Recruitment Status : Active, not recruiting
First Posted : February 11, 2014
Last Update Posted : May 24, 2017
Sponsor:
Collaborators:
Centre for Infectious Disease Research in Zambia
University of Bern
Information provided by (Responsible Party):
Michael Vinikoor, University of Alabama at Birmingham

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : June 2021
  Estimated Study Completion Date : June 2021
Publications:
KASOLO, F. (2003) Hepatitis B virus infection in human immunodeficiency virus seropositive patients at the University Teaching Hospital, Lusaka, Zambia: Interrelationship. IN SAKALA, I. (Ed.) Abstract no. B12601. The XV International Aids Conference, International Aids Society.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):